ADIPOQ and fatty liver disease: Our observations support previous reports that this isomer is responsible for decreased weight gain, increased liver weight, diminished adiponectin levels, hyperinsulinemia and the development of hepatic steatosis [3], [33], [35], [43], [44], [53]–[56].